Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-25-001067
Filing Date
2025-07-18
Accepted
2025-07-18 16:05:56
Documents
1
Period of Report
2025-07-16

Document Format Files

Seq Description Document Type Size
1 e664707_4-vitt.html 4  
1 e664707_4-vitt.xml 4 14024
  Complete submission text file 0001193805-25-001067.txt   15551
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address IMMUNIC AG AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address
Vitt Daniel (Reporting) CIK: 0001773673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 251134565